Results of a study investigating ibrutinib combined with lenalidomide and rituximab for first line treatment of DLBCL. (Abstract only)
Home / Resource Library / Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma